Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial

BACKGROUND: Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y(12) blocker is currently standard care after percutaneous coronary intervention (PCI) with stent insertion, and aims to inhibit platelet function in order to prevent stent thrombosis. The P2Y(12) blocker ticagrelor (TIC) has g...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Baos, Sarah, Underwood, Wendy, Culliford, Lucy, Reeves, Barnaby C., Rogers, Chris A., Bowles, Ruth, Johnson, Tom, Baumbach, Andreas, Mumford, Andrew
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680755/
https://ncbi.nlm.nih.gov/pubmed/29121979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2277-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars